Cannabis Sativa

thcscience_admin
Viviana Gradinaru

Viviana Gradinaru

Professor of Neuroscience and Biological Engineering at Caltech
Verified email at caltech.edu
Cited by 29973
Neuroscience Optogenetics AAV Gene Therapy Bioengineering
Luk H. Vandenberghe, Ph.D.

Luk H. Vandenberghe, Ph.D.

Grousbeck Family Chair in Gene Therapy, Associate Professor of Ophthalmology, Harvard …
Verified email at meei.harvard.edu
Cited by 16545
Gene Therapy AAV Virology COVID-19 Vaccines
Dirk Grimm

Dirk Grimm

Heidelberg University Hospital
Verified email at bioquant.uni-heidelberg.de
Cited by 16404
AAV viral vectors gene therapy CRISPR RNAi
Daniel G. Miller

Daniel G. Miller

Professor of Pediatrics and Genome Sciences, University of Washington
Verified email at uw.edu
Cited by 11177
Genetics AAV FSHD Facioscapulohumeral Muscular … Gene targeting Informatics
Thomas Weber

Thomas Weber

Spark Therapeutics
Verified email at sparktx.com
Cited by 9426
adeno-associated virus AAV gene therapy intracellular traffikcking
Ge Tan

Ge Tan

Novartis Institutes for BioMedical Research
Verified email at novartis.com
Cited by 8760
Computational Biology Bioinformatics Computational Genomics RNAi AAV
Michael Chapman

Michael Chapman

University of Missouri
Verified email at missouri.edu
Cited by 8751
Structural Biology AAV Virology Gene Therapy Protein Dynamics
Xiaojun Liu

Xiaojun Liu

ReciBioPharm (ReciPharm)
Verified email at arrantabio.com
Cited by 7964
Gene Therapy AAV Process Development Molecular Biology Protein Engineering
Deniz Dalkara

Deniz Dalkara

1 INSERM, U968, Paris, F-75012, France; 2 Sorbonne Universités, UPMC Univ Paris 06 …
Verified email at inserm.fr
Cited by 7782
Gene therapy Retina Optogenetics Viral gene delivery AAV
Christian Mueller

Christian Mueller

Global Head of Genomic Medicine -Sanofi Genzyme
Verified email at sanofi.com
Cited by 6850
CAS9 RNAi COPD AAV ALS
1 - 10

Leave a Reply